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As the population increases in age, the diseases of older age will have increasing prevalence and place a greater burden on the 
health system. Despite asthma being usually considered a disease of younger people, asthma mortality is currently greatest in the 
over 55 age-group. Symptoms and emergency presentations for health care due to asthma place a great burden on the quality of life 
of those over age 55 with asthma. Asthma in older people is under-diagnosed due to patient and physiological factors. Medication 
strategies for asthma have been dominantly derived from younger cohorts so that effective medication strategies have usually not 
been explored in older people. Older people with asthma are very concerned regarding side effects of medication so that adherence 
to therapeutic regimes is often poor. In addition physical disability can lead to difficulty in accessing treatment and using inhaler 
devices. Practical strategies to improve asthma outcomes in older people have been studied infrequently and the goals of self-
management suitable for younger age-groups may not be applicable in this group. Consequently, asthma in older people is deserving 
of further attention both to basic mechanisms of disease, precision in diagnosis and effective therapeutic strategies, including those 
that involve self-management and device use. 
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IntroductIon
As the population ages, the prevalence of diseases of older 
age will rise. Whilst asthma is often considered a disease 
of younger people, the high prevalence of asthma in the 
community indicates that many older people suffer from asthma 
with its associated impact on morbidity and mortality. Moreover, 
mortality and morbidity statistics suggest that older people 
suffer disproportionately from the burden of asthma and airways 
disease with the majority of those dying from asthma aged over 
55 years. The reasons for this are multi-faceted and relate to the 
pulmonary changes of ageing, perceptions of dyspnoea and its 
meaning to older people, difficulties in asthma diagnosis, and 
the burden of medication and co-morbidities which render 
asthma in older age-groups a unique problem deserving of 
specific examination and therapeutic intervention. 
Older people are generally defined as being 65 years old 
or greater. In this age-group asthma is a common disease 
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affecting greater than 10% of the population [1, 2]. Characteristic 
of asthma are symptoms of wheeze, cough and/or shortness of 
breath together with detection of variable airflow obstruction. 
Key to the definition of asthma is evidence of airway inflammation 
and characteristic airway wall remodelling involving a thickened 
airway basement membrane and smooth muscle hypertrophy. 
Examination of airway inflammatory changes, often through 
examination of induced sputum, has indicated the importance 
of eosinophils in a majority of those with asthma, however in 
older age neutrophilic airway inflammation is more common 
[3]. By contrast, chronic obstructive airways disease is associated 
with airflow obstruction which is only partly reversible with 
inflammatory airway changes are dominantly neutrophilic. In 
addition, a history of cigarette smoking is common in older 
people and therefore diagnostic uncertainty frequently exists in 
obstructive airways diseases in older age-groups with subsequent 
confusion regarding correct treatments [4, 5]. Importantly, asthma 
demonstrates airflow obstruction which is variable and reversible. 
Clinical evidence suggests that asthma older age-groups has 
different characteristics from that in younger groups with a lower 
lung function and greater symptom severity [6]. Asthma in the 
elderly population is commonly classified according to the age of 
asthma diagnosis. “Late onset” asthma is first diagnosed after the 
age of 65 while “early onset” persists into older age. Late onset 
asthma is often a more severe phenotype, with less symptom free 
days, and a higher requirement for oral corticosteroids [6]. 
Late onset asthma patients tend to be less atopic with lower 
levels of serum IgE and both serum and sputum eosinophils. 
That is, they are likely to be non-atopic or have “intrinsic” asthma 
with evidence of sputum neutrophilia [6, 7]. Late onset atopic 
asthma is predicted by high levels of IgE and previous allergen 
sensitisation. However, allergen sensitisation can occur at any age. 
The Normative Ageing Study demonstrated that previous cat 
sensitisation was associated with late onset asthma as confirmed 
by methacholine bronchoprovocation testing [8].
normal ageing and the lung
Ageing is associated with a restricted chest wall as thoracic 
skeletal components become stiffer and less compliant [9]. Age 
related deterioration and calcification in the rib articulations 
appear to explain these findings. There is additional evidence 
that the contractile properties of the diaphragm deteriorate 
with ageing [10]. In addition, normal aging is associated with a 
reduction in elastic recoil of the lung due to loss of elastic fibres. In 
expiration the loss of elastic recoil leads to small airways collapse 
with associated air trapping and in increase in the residual volume, 
a normal finding in ageing. There is also a decrease in the vital 
capacity as a result of a stiffer chest wall and muscle weakness. As 
a result, the ageing lung is put at a mechanical disadvantage. 
diagnostic challenges
The diagnosis of late onset asthma can be difficult and delayed. 
There are both patient and physician factors underlying the 
problem. Connolly et al. [11] demonstrated that elderly asthmatics 
have a reduced awareness of acute bronchoconstriction following 
a methacholine challenge compared to younger asthmatics 
patients. Further, Ekici et al. [12] performed an airway challenge 
on an asthmatic population. Elderly asthmatics reported less 
breathlessness on Borg dyspnoea score compared to the young 
asthmatics for a comparable level of bronchoconstriction. 
Furthermore, even when dyspnoea is recognised, older patients 
may regard their symptoms as a consequence of old age and 
therefore not report their dyspnoea to doctors [13]. Low socio-
economic status may result in lack of access to health care, 
contributing to such under-reporting in an elderly population [1, 
13]. 
Studies in older populations confirm substantial under-diagnosis 
by as much as 50%. In a community sample, 3.9% of patients 
had been diagnosed with asthma by a physician, however, a 
further 4.1% of patients had undiagnosed yet probable asthma 
[14]. Furthermore, Dow and co-workers [15], in a cross sectional 
survey of 6,000 residents of Bristol over the age of 65, not taking 
asthma treatments, reported an estimated population prevalence 
for untreated asthma of 1.7%. The majority of these patients 
(84%) had moderate or severe disease as defined by spirometric 
parameters. A history of wheeze and breathlessness or a past 
history of doctor diagnosed asthma were most likely to indicate 
untreated asthma [15]. 
The diagnostic challenge is exacerbated by the reduced 
reliability of normal predicted spirometry values in the elderly 
population which are frequently extrapolated from younger age-
groups [16]. Further, old age (71-73 years) was an independent 
predictor for unsuccessful spirometry as defined by American 
Thoracic Society testing criteria amongst a Norwegian randomly 
selected population [17]. 
Prevalence
The over-all prevalence of asthma over the life-span indicates apallergy.org
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that the prevalence of current asthma peaks in the 10 to 24 year 
old age-group with a reported prevalence of between 3 and 
18% [18]. Whilst many children do grow out of asthma recent 
longitudinal cohorts suggest that asthma may remit in as many as 
65% of children with asthma, but asthma that occurs in adulthood 
is less likely to remit [19]. The prevalence of current asthma in 
those over 65 years has been documented in Australia as between 
7.5 and 12.5%, with a predominance of females [1]. Data from 
the USA suggests a prevalence between 4 and 10%, again with 
a predominance of females [2]. One of the controversies in the 
diagnosis of asthma in older people is the overlap with chronic 
obstructive airways disease so that a diagnosis of asthma is often 
considered less certain in this age-group. However Abramson and 
co-workers undertook a careful examination of airways disease 
by complex spirometry in people over age 50 and showed that 
asthma was evident in 55% of those with obstructive lung disease 
with syndromes overlapping with asthma evident in only 8% of 
subjects [20].
Morbidity and mortality
Asthma in the elderly is responsible for a significant and 
increasing mortality in the elderly population. Asthma deaths are 
highly over-represented by the elderly population. In Australia 
between 2003 and 2007 sixty-nine percent of all asthma deaths 
were in those 65 years and above [1]. In 2009, 259/411 asthma 
related deaths in Australia were over the age of seventy [21]. The 
pattern of mortality in older people with asthma also differs from 
younger age-groups with the peak time of death occurring over 
winter months, in contrast to the more even spread of mortality 
throughout the year in the 5 to 64 year old age groups, suggesting 
a potential infective cause of death [1, 2].
Asthma in older age-groups has been observed to impact on 
survival. Bellia et al. [22] assessed the mortality rate amongst 210 
elderly asthmatic patients and 1,023 controls with a chronic non-
respiratory condition. The five year mortality rate was 24% in the 
asthmatics and 16% in the controls, however the difference in 
mortality was not attributable to respiratory disease. A population-
based study in Rochester, Minnesota reported an incidence of 
95/100,000 for the diagnosis of late onset asthma. Forty-two 
percent of these patients had at least one hospital admission. In 
this study, the observed survival was not significantly different 
from the expected survival [23], an observation confirmed by 
Australian data [1].
Increased health service utilisation is also evident in the older 
age-group with 36% of those interviewed in an Australian cohort 
of over 55 year olds with asthma claiming an emergency visit to 
a medical practitioner or hospital in the previous 12 months [13]. 
Hospital statistics also testify to the relatively high rate of hospital 
admission for asthma in older age-groups with the 65 and older 
group having slightly higher admission rates for asthma than 
the 15 to 34-year-old age-group [1, 2]. Once in hospital the older 
group had a significantly longer length of stay [1]. 
Quality of life 
Enright et al. [14] surveyed a community sample of 2,527 elderly 
patients with and without asthma. Asthma was associated with 
a reduced quality of life. Asthmatics also reported increased 
impairment in activities of daily living and were twice as likely to 
have symptoms of depression. Asthmatics were more likely to rate 
their general health as fair or poor.
Quality of life was also assessed in elderly (>70 years) asthmatics 
and non-asthmatic controls in a general practice population 
using the Short Form (SF)-36 and the St. George’s Respiratory 
Questionnaire (SGRQ) [24]. Quality of life was significantly impaired 
in the asthmatic population. Asthmatics reported significantly 
impaired quality of life in the physical, social and general health 
domains of the SF-36 and in all domains of the SGRQ. Elderly 
asthmatics also reported more depressive symptoms than the 
controls [24].  
Plaza et al. [25] performed a cross-sectional study in an 
asthmatic population in a county of Barcelona addressing both 
quality of life and direct economic impact of asthma in the elderly 
(>65 years) versus an adult (<65 years) population. Again, asthma 
in the elderly was associated with reduced quality of life across 
all domains of the SGRQ. Asthma was more severe in the elderly 
with significantly more patients (55% vs. 18%) classified as severe. 
Asthma derived direct costs in the elderly were double than the 
adult population. Most of this excess expense was explained by 
hospitalisation costs [25]. 
Lung function
Weiner et al. [26] measured lung function and recorded 
asthma symptom scores in 30 consecutive elderly asthmatics, 
15 diagnosed prior to (long-standing), and 15 after the age of 65 
years (late-onset). Fifteen young asthmatics, aged under 65 were 
also included in this analysis. Elderly patients with longstanding 
asthma had the most severe airway obstruction and importantly, 
also complained of fewer asthma symptoms.apallergy.org
gillman a, et al.
Asia Pacific
allergy
http://dx.doi.org/10.5415/apallergy.2012.2.2.101 104
Asthma is a chronic inflammatory condition that has been 
shown to be correlated with a slow but progressive loss of lung 
function over time. Lange et al. [27] presented the results of a 
longitudinal epidemiological study of 17,506 Danish subjects of 
which 1,095 had asthma studied over a 15 year period. Asthmatics‘ 
rate of lung function/FEV1 decline was 38 mL/year which was 
significantly greater than the normals at 22 mL/year. These results 
stress the importance of good asthma control and the impact in 
the elderly asthmatic population where a prolonged duration of 
disease is evident.
treatment
Pharmacological treatment of asthma in the elderly needs to 
be administered with care as this population are more likely to 
experience medication side effects and are also more likely to 
suffer from drug-drug interactions [28, 29]. Beta-agonist therapy 
can cause tremor, a dose dependent reduction in serum potassium 
and tachycardia. Tremor is a common concern in the elderly 
asthmatic and it is caused by β2 stimulation of skeletal muscle. To 
minimise systemic absorption though oropharyngeal deposition 
a spacer device is recommended [28]. Older people particularly 
attribute side effects to reliever medication and are concerned by 
these, frequently being unfamiliar with an “as needed” approach 
to inhaled β-agonist therapy [13].
Theophylline is recommended in patients with uncontrolled 
asthma despite combination inhaler therapy – Global Initiative for 
Asthma (GINA - Step 3) [31]. Theophylline must be used carefully in 
the elderly population and is associated with a number of adverse 
effects particularly when drug levels are above the therapeutic 
range. Drug toxicity is most likely in those with established 
cardiac or liver disease and there are a number of described drug 
interactions eg. quinolones and allopurinol. Careful monitoring of 
drug levels is required to reduce the risk of very serious adverse 
events such as cardiac arrhythmias and seizures. However, side 
effects including nausea, insomnia and gasto-oesophageal reflux 
disease are not uncommon. 
Inhaled steroids at moderate doses are generally not associated 
with systemic side effects in the elderly population. However, local 
side effects are not uncommon and include oral candidiasis and 
hoarseness of the voice. These effects are dose-dependent and 
can usually be managed with the addition of a spacer device. The 
fear of corticosteroid side effects are substantial in this age-group 
and are emphasised by the increasing frequency of cataracts and 
osteoporosis which are associated with “steroid” therapy in this 
age-group [13, 30]. 
Systemic corticosteroids can cause or exacerbate significant 
systemic adverse effects in the elderly population including 
diabetes, cataracts, hypertension, osteoporosis and vertebral 
fractures. Systemic maintenance corticosteroids are however 
indicated for severe, uncontrolled asthma indicated at the higher 
steps of the GINA treatment recommendations [31]. 
A qualitative survey of elderly Australian asthmatics observed 
that 37% of respondents were concerned about medication side-
effects. Further, 41% reported side-effects from their preventer 
medication most commonly including voice changes and a sore 
dry throat. Fifty-one prevent reported adverse outcomes from 
their reliever medication, particularly tremor. Such concerns 
constitute a significant barrier to regular asthma medication use [13, 
30].
Beta-2 agonists are recommended as first line reliever therapy in 
asthma guidelines [31, 32]. Across the entire population β-agonists 
are superior bronchodilators and have a more rapid onset action 
than anti-cholinergic medication. However, there is a reduced 
expression/function of beta receptors in the lung related to 
ageing. Cholinergic receptors appear to function independently 
of ageing. As a consequence, there is a reduction in response to 
β-agonist bronchodilator therapy associated with ageing which 
has not been seen with anti-cholinergics. Indeed, some elderly 
patients respond better to anti-cholinergics than to beta agonists 
[33]. These findings have not translated into specific treatment 
guidelines. 
Elderly patients with severe allergic asthma should also be 
considered for omalizumab therapy. The GINA guidelines [31] 
recommend this medication as “Step 4” add-on treatment. A 
subgroup analysis demonstrated that elderly patients also gain 
benefit from this medication [34].
Elderly patients are often prescribed a number of medical 
treatments for medical comorbidities. There is a list of medication 
that can trigger or exacerbate asthma. For example, β-blockers are 
prevalent and used for hypertension and ischemic heart disease. 
There are case reports of timolol, a non-selective beta blocker, 
used for glaucoma triggering severe and fatal bronchospasm 
[35]. Non-steroidal anti-inflammatory medications used for 
osteoarthritic pain, highly prevalent in the elderly population, can 
also exacerbate asthma.
Lack of access to medical care is a problem in the elderly 
population. Medical visits may represent a significant financial 
hardship in the elderly population where in retirement income apallergy.org
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is often fixed. Further, physical frailty is also likely to exacerbate 
the difficulties of visiting medical doctors [13, 36]. Finally, there 
has been qualitative research reporting that elderly patients are 
reluctant to seek emergency care because they believe they are 
not deserving [37]. These factors are likely to contribute to reduced 
utilisation of medical care. 
Elderly patients have a reduced perception of airflow 
obstruction [11, 12]. There is also a reduced cough reflex [38]. 
These factors are also likely to contribute to delayed presentation 
of asthma exacerbations. In order for asthma action plans to be 
effective in older age-groups they should observe the differences 
in the elderly population and be tailored to individuals [39].
Population-based studies have consistently demonstrated 
under-treatment of asthma in the elderly. In a community sample 
[14], of those with definite asthma, thirty nine percent were on 
no asthma treatment which included 6/20 patients with severe 
asthma. Further, only forty percent were using reliever medications 
and thirty percent inhaled corticosteroids.
Self management of asthma
Asthma action plans are an important strategy in asthma 
management. They are important in that they are effective 
in improving asthma outcomes in the paediatric and adult 
population when provided in written form [40]. Evidence from a 
case-control study of people who had died from asthma showed 
that the presence of an action plan was a major protective factor 
against death from asthma [40]. Of concern, there is evidence that 
action plans are less likely to be provided to elderly asthmatics [39]. 
In a survey of elderly asthmatics 66% participants wanted more 
information about their asthma. The preferred method was a 
conversation with a doctor or receipt of written information sheets 
[30]. A qualitative study of primary care physicians surprisingly 
revealed that action plans were not a priority in patient asthma 
management. These observations were partly explained by the 
perceived barriers in primary care such as the short consultation 
duration [41]. Asthma education strategies have largely been 
developed in paediatric and mixed age-groups [42] so that 
evidence of effectiveness of asthma self-management education 
in older age-groups is sparse [4, 30]. Whilst some studies of 
educational strategies for asthma specifically targeted to older 
people provide evidence of efficacy [43] the evidence is not 
uniform [44], suggesting that further study in the area of what 
constitutes an effective educational strategy in older people with 
asthma is indicated.
Medication adherence 
Medication non-adherence is a problem when managing 
any medical patient and asthma is no exception. Patients with 
severe asthma who are non-adherent have poor symptom 
control, increased reliever medication, and increased emergency 
department presentations and hospital admissions [45]. Krishnan 
and colleagues [46] used electronic medication monitoring in 
asthmatics following discharge from hospital with an asthma 
exacerbation. Within seven days of discharge there was fifty 
percent non-adherence to both inhaled and oral corticosteroids 
[46]. In an important study, Sin et al. [47] identified 6,254 
consecutive admissions to hospital with asthma in Ontario Canada 
in patients aged over 65 years. Those patients identified as users 
of inhaled steroids post discharge by collecting an additional 
inhaled corticosteroid medication within 90 days of discharge 
were 29% less likely to be readmitted to hospital with asthma 
and 39% less likely to experience ‘all cause mortality’ over a 1-year 
follow-up period [47]. This study supports the efficacy of inhaled 
corticosteroids in older people.
Non-adherence can unintentional. Community based studies 
describe suboptimal drug delivery with both metered dose 
inhalers (MDI) and dry-powder devices in an elderly population [48, 
49]. These observations highlight the need to consider the capacity 
of the elderly population when prescribing asthma medication. 
Firstly, elderly patients require sufficient cognitive capacity to 
learn, plan and sequence the correct inhaler technique. Allen et 
al. [49] observed that the uptake of successful inhaler technique 
(both MDI and turbohaler) is unlikely to be successful in an elderly 
population with a reduced Mini-Mental State Examination (MMSE). 
In those with a MMSE >23 18/19 subjects correctly used an MDI. 
Physical capacity also need to be considered when prescribing 
asthmatic medications. Dry powder inhalers require sufficient 
inspiratory flow generated by the patient in ordered to generate 
adequate drug delivery. Severe arthritis and dyspraxia affecting 
the hands can also adversely affect the ability to achieve the co-
ordination required to ensure adequate drug delivery. The addition 
of spacer devices can improve the performance of MDIs and are 
routinely recommended. MDI and MDI and spacer technique was 
taught to 40 naïve elderly (mean age 78) patients with obstructive 
airways disease. Following the education session 30% of MDI 
patients had inadequate technique compared to only 8% of 
the MDI and spacer patients. Further, MDI and spacer was the 
preferred delivery device of the patients [50]. Importantly, effective 
device education can improve technique and can be utilised in apallergy.org
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the pharmacy [51]. For those symptomatic asthmatic patients with 
significant cognitive or physical disability nebulised preventer 
medication is an alternative. 
Non-adherence to asthma treatment can also be intentional. 
The physician must consider the possible risk factors for intentional 
non adherence so they can be addressed proactively. These factors 
can broadly be considered as physical, financial, treatment related 
and psychosocial [52]. Physical and financial barriers to treatment 
adherence are due to difficulties of access to medication which can 
indicate the physical incapacity of older age and the restrictions 
of retirement-incomes in older people. Treatment-related side 
effects are a major concern to older people with a survey of over-
55 year old Australian patients indicating that 37% were worried 
about treatment side effects while 41% reported experiencing side 
effects from asthma medication [30].
Bozek et al. [53] identified poor cognition and depression as 
major risk factors for poor adherence in an elderly asthmatic 
population. Poor compliance was associated poor asthma control 
as measured by the Asthma Control Test. Further, one year of close 
monitoring (electronic diary and drug packages) of these patients 
had a positive impact on adherence. Moreover in those effectively 
treated, asthma and cognition were seen to improve [54]. 
concLuSIon
Asthma in the elderly is associated with significant morbidity 
and mortality and requires careful monitoring. People over age 
65 with asthma have fewer symptoms of asthma and are less 
likely to report and present to medical care. The inhaled therapies 
required to control asthma are often not taken adequately 
because of physical or cognitive disability more evident in the 
elderly population Elderly patients also intentionally do not take 
their asthma medications for a broad range of reasons and the 
physician needs to carefully identify these factors in considering 
a symptomatic patient. Current controversies in the management 
of older people relate to the utility of asthma management 
education in this group, the effectiveness of current treatment 
algorithms which are dominantly derived from younger age-
groups and the cellular phenotype of asthma in the older person. 
To answer these questions, further specific work in basic disease 
mechanisms are required as well as work studying the application 
of current treatment regimens for asthma to the older population, 
including education to ensure that improved asthma outcomes 
are achieved.
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